PPD, a Wimington-based drug-research firm, reported stronger third-quarter results late Tuesday.
The company's revenue rose to $365.4 million, up 7 percent from the same period last year. Operating income of $56.8 million was a 10 percent improvement.
PPD, which celebrated its 25th anniversary this summer, has a large Triangle operation with about 1,400 local employees. The company conducts clinical trials for pharmaceutical companies developing experimental drugs, and provides other services.
It's one of the largest players in the contract research organization industry, which is concentrated in the Triangle.
PPD shares closed Tuesday at $25.72, up 38 cents.
PPD executives, including CEO David Grange, will discuss the latest results at 9 a.m. Listen to that discussion here.
Assistant Business Editor Alan M. Wolf joined the N&O in 1999 covering the business of health care. He became an editor in 2001, and helps oversee the paper's daily business coverage and Sunday Work&Money section. He lives in Clayton with his wife and two children. Reach him at 919-829-4572 or